Moderna says mRNA flu vaccine sailed through trial, beating standard shot Moderna hailed the results, but the shot's future under RFK Jr. is murky.

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major trial, the company announced.

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major trial, the company announced Monday.

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the company’s mRNA-1010 flu vaccine’s efficacy was nearly 27 percent ...

Moderna Inc. said its experimental flu shot met its goal in a late-stage trial, clearing the path for its broader strategy of selling combination vaccines. The shot’s efficacy was 27 percent ...

Mercury-based preservative thimerosal is in the spotlight, as a CDC committee votes to recommend single-dose flu vaccines without the controversial ingredient for all age groups.

Current flu vaccines contain three different strains of influenza, which are selected by doctors who monitor what strains are circulating toward the tail end of the prior flu season.

This San Antonio, Tex., lab takes biosecurity seriously. Suit up with its scientists and go behind the scenes of the science of vaccine creation.

Hand‑picked CDC panel endorses flu shots for all but recommends avoiding thimerosal vials—a win for skeptics that may affect cost and trust.

Robert F. Kennedy Jr.’s vaccine panel votes to stop recommending flu shots containing thimerosal, which government agencies and medical experts say is safe.

Although a flu shot doesn’t guarantee one won’t catch the flu, the vaccine still counts as one of the most effective lifesaving public health tools we have.

Cambodia registered its fifth bird flu death this year after a 52-year-old man died from the virus, the health ministry said on Saturday.